The mission of this Program is to prepare a cadre of outstanding cancer epidemiologists through rigorous academic training in research methodology and the epidemiology and biology of cancer, and mentored research. Additional emphasis is placed on molecular and genetic epidemiology methods and applications. A distinguished faculty provides a variety of substantial opportunities for research experience. There are three types of trainees: Doctoral Candidates in Epidemiology includes pre-doctoral candidates either with or without a prior doctoral degree (generally clinicians) who undertake 2-3 years of coursework, in addition to research, in the course of earning a doctoral degree in Epidemiology;Clinical Researchers include physicians with specialty training in cancer preparing for careers in clinical epidemiology who undertake a one year Master's degree program in methodology followed by a year of research;and Post- doctoral Fellows who hold a prior doctoral degree in Epidemiology or in Biology and undertake mentored research (and with coursework if needed) in preparation for an academic career. Those trainee positions are generally awarded for 2 or 3 years. The number of trainee positions requested includes five pre-doctoral students and seven post-doctoral fellows, for a total of 12 trainees. The program had supported 16 trainees since 1998, but at the behest of the NIH project officer, we have reduced the requested number to 12. The Program is based in the Department of Epidemiology of the Harvard School of Public Health, and is also affiliated with the Channing Division of Network Medicine in the Department of Medicine, Brigham and Women's Hospital. A dedicated molecular epidemiology laboratory is available. This proposal continues a long history of excellence in training in cancer epidemiology at Harvard University;the current training program is now in its 37th year, with an outstanding record of achievement in training.

Public Health Relevance

Knowledge about cancer epidemiology - the study of the determinants and distribution of cancer in human populations - has grown exponentially. With major advances in methodology, cancer biology and genetics, the need for well-trained highly skills researchers and clinicians in this area has never been greater. We propose, through this training grant, to continue to provide high quality cancer epidemiology training to educate the next generation of outstanding scholars and public health researchers in this vital field.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA009001-39
Application #
8667244
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1978-07-01
Project End
2019-06-30
Budget Start
2014-08-29
Budget End
2015-06-30
Support Year
39
Fiscal Year
2014
Total Cost
$613,606
Indirect Cost
$40,710
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Busch, Evan L; Keku, Temitope O; Richardson, David B et al. (2016) Evaluating markers of epithelial-mesenchymal transition to identify cancer patients at risk for metastatic disease. Clin Exp Metastasis 33:53-62
Semu, Helen; Zack, Rachel M; Liu, Enju et al. (2016) Prevalence and Risk Factors for Overweight and Obesity among HIV-Infected Adults in Dar es Salaam, Tanzania. J Int Assoc Provid AIDS Care 15:512-521
Hirko, Kelly A; Fortner, Renée T; Hankinson, Susan E et al. (2016) Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II. Breast Cancer Res Treat 158:149-55
Ahearn, Thomas U; Pettersson, Andreas; Ebot, Ericka M et al. (2016) A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. J Natl Cancer Inst 108:
Birmann, Brenda M; Barnard, Mollie E; Bertrand, Kimberly A et al. (2016) Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic. Am J Public Health 106:1608-15
Charlton, Brittany M; Mølgaard-Nielsen, Ditte; Svanström, Henrik et al. (2016) Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study. BMJ 352:h6712
Hirko, Kelly A; Willett, Walter C; Hankinson, Susan E et al. (2016) Healthy dietary patterns and risk of breast cancer by molecular subtype. Breast Cancer Res Treat 155:579-88
Hartman, Terryl J; Sisti, Julia S; Hankinson, Susan E et al. (2016) Alcohol Consumption and Urinary Estrogens and Estrogen Metabolites in Premenopausal Women. Horm Cancer 7:65-74
Hart, Jaime E; Bertrand, Kimberly A; DuPre, Natalie et al. (2016) Long-term Particulate Matter Exposures during Adulthood and Risk of Breast Cancer Incidence in the Nurses' Health Study II Prospective Cohort. Cancer Epidemiol Biomarkers Prev 25:1274-6
Sanchez, A; Schoenfeld, J D; Nguyen, P L et al. (2016) Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment. Prostate Cancer Prostatic Dis 19:197-201

Showing the most recent 10 out of 397 publications